Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Review Article

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Author(s): Siyu Hao, Dan Cai, Shuang Gou, Yan Li, Lin Liu, Xiaolong Tang, Yu Chen, Yueshui Zhao, Jing Shen, Xu Wu, Mingxing Li, Meijuan Chen, Xiaobing Li, Yuhong Sun, Li Gu, Wanping Li, Fang Wang, Chi Hin Cho, Zhangang Xiao* and Fukuan Du*

Volume 31, Issue 31, 2024

Published on: 10 August, 2023

Page: [4958 - 4986] Pages: 29

DOI: 10.2174/0929867331666230719142202

open access plus

Open Access Journals Promotions 2
Abstract

Reactive oxygen species (ROS) are a class of highly reactive oxidizing molecules, including superoxide anion (O2 •−) and hydrogen peroxide (H2O2), among others. Moderate levels of ROS play a crucial role in regulating cellular signaling and maintaining cellular functions. However, abnormal ROS levels or persistent oxidative stress can lead to changes in the tumor microenvironment (TME) that favor cancer development. This review provides an overview of ROS generation, structure, and properties, as well as their effects on various components of the TME. Contrary to previous studies, our findings reveal a dual effect of ROS on different components of the TME, whereby ROS can either enhance or inhibit certain factors, ultimately leading to the promotion or suppression of the TME. For example, H2O2 has dual effects on immune cells and non-- cellular components within the TME, while O2 •− has dual effects on T cells and fibroblasts. Furthermore, each component demonstrates distinct mechanisms of action and ranges of influence. In the final section of the article, we summarize the current clinical applications of ROS in cancer treatment and identify certain limitations associated with existing therapeutic approaches. Therefore, this review aims to provide a comprehensive understanding of ROS, highlighting their dual effects on different components of the TME, and exploring the potential clinical applications that may pave the way for future treatment and prevention strategies.

Keywords: ROS, tumor, microenvironment, molecule, metabolism, therapy.

« Previous Next »
[1]
Anderson, N.M.; Simon, M.C. The tumor microenvironment. Curr. Biol., 2020, 30(16), R921-R925.
[http://dx.doi.org/10.1016/j.cub.2020.06.081] [PMID: 32810447]
[2]
Deepak, K.G.K.; Vempati, R.; Nagaraju, G.P.; Dasari, V.R.; S, N.; Rao, D.N.; Malla, R.R. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol. Res., 2020, 153, 104683.
[http://dx.doi.org/10.1016/j.phrs.2020.104683] [PMID: 32050092]
[3]
Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: the next generation. Cell, 2011, 144(5), 646-674.
[http://dx.doi.org/10.1016/j.cell.2011.02.013] [PMID: 21376230]
[4]
Weinberg, F.; Hamanaka, R.; Wheaton, W.W.; Weinberg, S.; Joseph, J.; Lopez, M.; Kalyanaraman, B.; Mutlu, G.M.; Budinger, G.R.S.; Chandel, N.S. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. USA, 2010, 107(19), 8788-8793.
[http://dx.doi.org/10.1073/pnas.1003428107] [PMID: 20421486]
[5]
Kong, H.; Chandel, N.S. Regulation of redox balance in cancer and T cells. J. Biol. Chem., 2018, 293(20), 7499-7507.
[http://dx.doi.org/10.1074/jbc.TM117.000257] [PMID: 29282291]
[6]
Martinez-Outschoorn, U.E.; Balliet, R.M.; Rivadeneira, D.; Chiavarina, B.; Pavlides, S.; Wang, C.; Whitaker-Menezes, D.; Daumer, K.; Lin, Z.; Witkiewicz, A.; Flomenberg, N.; Howell, A.; Pestell, R.; Knudsen, E.; Sotgia, F.; Lisanti, M.P. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution. Cell Cycle, 2010, 9(16), 3276-3296.
[http://dx.doi.org/10.4161/cc.9.16.12553] [PMID: 20814239]
[7]
Moloney, J.N.; Cotter, T.G. ROS signalling in the biology of cancer. Semin. Cell Dev. Biol., 2018, 80, 50-64.
[http://dx.doi.org/10.1016/j.semcdb.2017.05.023] [PMID: 28587975]
[8]
Mittler, R. ROS are good. Trends Plant Sci., 2017, 22(1), 11-19.
[http://dx.doi.org/10.1016/j.tplants.2016.08.002] [PMID: 27666517]
[9]
Weinberg, F.; Ramnath, N.; Nagrath, D. Reactive oxygen species in the tumor microenvironment: An overview. Cancers (Basel), 2019, 11(8), 1191.
[http://dx.doi.org/10.3390/cancers11081191] [PMID: 31426364]
[10]
Galadari, S.; Rahman, A.; Pallichankandy, S.; Thayyullathil, F. Reactive oxygen species and cancer paradox: To promote or to suppress? Free Radic. Biol. Med., 2017, 104, 144-164.
[http://dx.doi.org/10.1016/j.freeradbiomed.2017.01.004] [PMID: 28088622]
[11]
Kirtonia, A.; Sethi, G.; Garg, M. The multifaceted role of reactive oxygen species in tumorigenesis. Cell. Mol. Life Sci., 2020, 77(22), 4459-4483.
[http://dx.doi.org/10.1007/s00018-020-03536-5] [PMID: 32358622]
[12]
Halliwell, B. Oxidative stress and cancer: have we moved forward? Biochem. J., 2007, 401(1), 1-11.
[http://dx.doi.org/10.1042/BJ20061131] [PMID: 17150040]
[13]
Nakazawa, M.S.; Keith, B.; Simon, M.C. Oxygen availability and metabolic adaptations. Nat. Rev. Cancer, 2016, 16(10), 663-673.
[http://dx.doi.org/10.1038/nrc.2016.84] [PMID: 27658636]
[14]
Xiao, Z.; Dai, Z.; Locasale, J.W. Metabolic landscape of the tumor microenvironment at single cell resolution. Nat. Commun., 2019, 10(1), 3763.
[http://dx.doi.org/10.1038/s41467-019-11738-0] [PMID: 31434891]
[15]
Kumar, S.; Sharife, H.; Kreisel, T.; Mogilevsky, M.; Bar-Lev, L.; Grunewald, M.; Aizenshtein, E.; Karni, R.; Paldor, I.; Shlomi, T.; Keshet, E. Intra-tumoral metabolic zonation and resultant phenotypic diversification are dictated by blood vessel proximity. Cell Metab., 2019, 30(1), 201-211.e6.
[http://dx.doi.org/10.1016/j.cmet.2019.04.003] [PMID: 31056286]
[16]
Velayutham, M.; Hemann, C.; Zweier, J.L. Removal of H2O2 and generation of superoxide radical: Role of cytochrome c and NADH. Free Radic. Biol. Med., 2011, 51(1), 160-170.
[http://dx.doi.org/10.1016/j.freeradbiomed.2011.04.007] [PMID: 21545835]
[17]
Edmondson, D. Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implications. Curr. Pharm. Des., 2014, 20(2), 155-160.
[http://dx.doi.org/10.2174/13816128113190990406] [PMID: 23701542]
[18]
Loschen, G.; Azzi, A.; Richter, C.; Flohé, L. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Lett., 1974, 42(1), 68-72.
[http://dx.doi.org/10.1016/0014-5793(74)80281-4] [PMID: 4859511]
[19]
Buettner, G.R.; Ng, C.F.; Wang, M.; Rodgers, V.G.J.; Schafer, F.Q. A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic. Biol. Med., 2006, 41(8), 1338-1350.
[http://dx.doi.org/10.1016/j.freeradbiomed.2006.07.015] [PMID: 17015180]
[20]
Roscoe, J.M.; Sevier, C.S. Pathways for sensing and responding to hydrogen peroxide at the endoplasmic reticulum. Cells, 2020, 9(10), 2314.
[http://dx.doi.org/10.3390/cells9102314] [PMID: 33080949]
[21]
Aviello, G.; Knaus, U.G. NADPH oxidases and ROS signaling in the gastrointestinal tract. Mucosal Immunol., 2018, 11(4), 1011-1023.
[http://dx.doi.org/10.1038/s41385-018-0021-8] [PMID: 29743611]
[22]
Sirokmány, G.; Geiszt, M. The relationship of NADPH oxidases and heme peroxidases: Fallin’ in and out. Front. Immunol., 2019, 10, 394.
[http://dx.doi.org/10.3389/fimmu.2019.00394] [PMID: 30891045]
[23]
Bienert, G.P.; Schjoerring, J.K.; Jahn, T.P. Membrane transport of hydrogen peroxide. Biochim. Biophys. Acta Biomembr., 2006, 1758(8), 994-1003.
[http://dx.doi.org/10.1016/j.bbamem.2006.02.015] [PMID: 16566894]
[24]
Lefèvre, C.T.; Bennet, M.; Landau, L.; Vach, P.; Pignol, D.; Bazylinski, D.A.; Frankel, R.B.; Klumpp, S.; Faivre, D. Diversity of magneto-aerotactic behaviors and oxygen sensing mechanisms in cultured magnetotactic bacteria. Biophys. J., 2014, 107(2), 527-538.
[http://dx.doi.org/10.1016/j.bpj.2014.05.043] [PMID: 25028894]
[25]
Katakwar, P.; Metgud, R.; Naik, S.; Mittal, R. Oxidative stress marker in oral cancer: A review. J. Cancer Res. Ther., 2016, 12(2), 438-446.
[http://dx.doi.org/10.4103/0973-1482.151935] [PMID: 27461591]
[26]
Marinho, H.S.; Real, C.; Cyrne, L.; Soares, H.; Antunes, F. Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol., 2014, 2, 535-562.
[http://dx.doi.org/10.1016/j.redox.2014.02.006] [PMID: 24634836]
[27]
Forman, H.J.; Maiorino, M.; Ursini, F. Signaling functions of reactive oxygen species. Biochemistry, 2010, 49(5), 835-842.
[http://dx.doi.org/10.1021/bi9020378] [PMID: 20050630]
[28]
Tochigi, M.; Inoue, T.; Suzuki-Karasaki, M.; Ochiai, T.; Ra, C.; Suzuki-Karasaki, Y. Hydrogen peroxide induces cell death in human TRAIL-resistant melanoma through intracellular superoxide generation. Int. J. Oncol., 2013, 42(3), 863-872.
[http://dx.doi.org/10.3892/ijo.2013.1769] [PMID: 23314732]
[29]
Okamoto, M.; Reddy, J.K.; Oyasu, R. Tumorigenic conversion of a non-tumorigenic rat urothelial cell line by overexpression of H2O2-generating peroxisomal fatty acyl-CoA oxidase. Int. J. Cancer, 1997, 70(6), 716-721.
[http://dx.doi.org/10.1002/(SICI)1097-0215(19970317)70:6<716::AID-IJC14>3.0.CO;2-7] [PMID: 9096654]
[30]
Hirst, J.; Carroll, J.; Fearnley, I.M.; Shannon, R.J.; Walker, J.E. The nuclear encoded subunits of complex I from bovine heart mitochondria. Biochim. Biophys. Acta Bioenerg., 2003, 1604(3), 135-150.
[http://dx.doi.org/10.1016/S0005-2728(03)00059-8] [PMID: 12837546]
[31]
Sazanov, L.A. Respiratory complex I: mechanistic and structural insights provided by the crystal structure of the hydrophilic domain. Biochemistry, 2007, 46(9), 2275-2288.
[http://dx.doi.org/10.1021/bi602508x] [PMID: 17274631]
[32]
Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J., 2009, 417(1), 1-13.
[http://dx.doi.org/10.1042/BJ20081386] [PMID: 19061483]
[33]
Kussmaul, L.; Hirst, J. The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria. Proc. Natl. Acad. Sci. USA, 2006, 103(20), 7607-7612.
[http://dx.doi.org/10.1073/pnas.0510977103] [PMID: 16682634]
[34]
Chance, B.; Hollunger, G. The interaction of energy and electron transfer reactions in mitochondria. I. General properties and nature of the products of succinate-linked reduction of pyridine nucleotide. J. Biol. Chem., 1961, 236(5), 1534-1543.
[http://dx.doi.org/10.1016/S0021-9258(18)64210-3] [PMID: 13692277]
[35]
Cino, M.; Del Maestro, R.F. Generation of hydrogen peroxide by brain mitochondria: The effect of reoxygenation following postdecapitative ischemia. Arch. Biochem. Biophys., 1989, 269(2), 623-638.
[http://dx.doi.org/10.1016/0003-9861(89)90148-3] [PMID: 2919886]
[36]
Hunte, C.; Palsdottir, H.; Trumpower, B.L. Protonmotive pathways and mechanisms in the cytochrome bc1 complex. FEBS Lett., 2003, 545(1), 39-46.
[http://dx.doi.org/10.1016/S0014-5793(03)00391-0] [PMID: 12788490]
[37]
Dröse, S.; Brandt, U. Molecular mechanisms of superoxide production by the mitochondrial respiratory chain. Adv. Exp. Med. Biol., 2012, 748, 145-169.
[http://dx.doi.org/10.1007/978-1-4614-3573-0_6] [PMID: 22729857]
[38]
Cadenas, E.; Boveris, A.; Ragan, C.I.; Stoppani, A.O.M. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys., 1977, 180(2), 248-257.
[http://dx.doi.org/10.1016/0003-9861(77)90035-2] [PMID: 195520]
[39]
Hayyan, M.; Hashim, M.A.; AlNashef, I.M. Superoxide ion: Generation and chemical implications. Chem. Rev., 2016, 116(5), 3029-3085.
[http://dx.doi.org/10.1021/acs.chemrev.5b00407] [PMID: 26875845]
[40]
Dietzel, P.D.C.; Kremer, R.K.; Jansen, M. Tetraorganylammonium superoxide compounds: close to unperturbed superoxide ions in the solid state. J. Am. Chem. Soc., 2004, 126(14), 4689-4696.
[http://dx.doi.org/10.1021/ja039880i] [PMID: 15070387]
[41]
Okada, F.; Kobayashi, M.; Tanaka, H.; Kobayashi, T.; Tazawa, H.; Iuchi, Y.; Onuma, K.; Hosokawa, M.; Dinauer, M.C.; Hunt, N.H. The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells. Am. J. Pathol., 2006, 169(1), 294-302.
[http://dx.doi.org/10.2353/ajpath.2006.060073] [PMID: 16816381]
[42]
Liu, R.; Li, B.; Qiu, M. Elevated superoxide production by active H-ras enhances human lung WI-38VA-13 cell proliferation, migration and resistance to TNF-α. Oncogene, 2001, 20(12), 1486-1496.
[http://dx.doi.org/10.1038/sj.onc.1204214] [PMID: 11313892]
[43]
Chaudhuri, J.; Chowdhury, A.A.; Biswas, N.; Manna, A.; Chatterjee, S.; Mukherjee, T.; Chaudhuri, U.; Jaisankar, P.; Bandyopadhyay, S. Superoxide activates mTOR–eIF4E–Bax route to induce enhanced apoptosis in leukemic cells. Apoptosis, 2014, 19(1), 135-148.
[http://dx.doi.org/10.1007/s10495-013-0904-9] [PMID: 24052408]
[44]
Thomas, C.; Mackey, M.M.; Diaz, A.A.; Cox, D.P. Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation. Redox Rep., 2009, 14(3), 102-108.
[http://dx.doi.org/10.1179/135100009X392566] [PMID: 19490751]
[45]
Chen, S.; Schopfer, P. Hydroxyl-radical production in physiological reactions. A novel function of peroxidase. Eur. J. Biochem., 1999, 260(3), 726-735.
[http://dx.doi.org/10.1046/j.1432-1327.1999.00199.x] [PMID: 10103001]
[46]
Babior, B.M. Phagocytes and oxidative stress. Am. J. Med., 2000, 109(1), 33-44.
[http://dx.doi.org/10.1016/S0002-9343(00)00481-2] [PMID: 10936476]
[47]
Wright, R.M.; McManaman, J.L.; Repine, J.E. Alcohol-induced breast cancer: a proposed mechanism. Free Radic. Biol. Med., 1999, 26(3-4), 348-354.
[http://dx.doi.org/10.1016/S0891-5849(98)00204-4] [PMID: 9895226]
[48]
Malins, D.C.; Gunselman, S.J.; Holmes, E.H.; Polissar, N.L. The etiology of breast cancer characteristic alterations in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer, 1993, 71(10), 3036-3043.
[http://dx.doi.org/10.1002/1097-0142(19930515)71:10<3036::AID-CNCR2820711025>3.0.CO;2-P] [PMID: 8387875]
[49]
Wang, Z.; Li, S.; Cao, Y.; Tian, X.; Zeng, R.; Liao, D.F.; Cao, D. Oxidative stress and carbonyl lesions in ulcerative colitis and associated colorectal cancer. Oxid. Med. Cell. Longev., 2016, 1-15.
[http://dx.doi.org/10.1155/2016/9875298] [PMID: 26823956]
[50]
Sumkhemthong, S.; Prompetchara, E.; Chanvorachote, P.; Chaotham, C. Cisplatin-induced hydroxyl radicals mediate pro-survival autophagy in human lung cancer H460 cells. Biol. Res., 2021, 54(1), 22.
[http://dx.doi.org/10.1186/s40659-021-00346-2] [PMID: 34321115]
[51]
Ren, J.G.; Xia, H.L.; Just, T.; Dai, Y.R. Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation. FEBS Lett., 2001, 488(3), 123-132.
[http://dx.doi.org/10.1016/S0014-5793(00)02377-2] [PMID: 11163758]
[52]
Tarr, M.; Valenzeno, D.P. Singlet oxygen: the relevance of extracellular production mechanisms to oxidative stress in vivo. Photochem. Photobiol. Sci., 2003, 2(4), 355-361.
[http://dx.doi.org/10.1039/b211778a] [PMID: 12760529]
[53]
Dogra, V.; Kim, C. Singlet oxygen metabolism: From genesis to signaling. Front. Plant Sci., 2020, 10, 1640.
[http://dx.doi.org/10.3389/fpls.2019.01640] [PMID: 31969891]
[54]
Di Mascio, P.; Martinez, G.R.; Miyamoto, S.; Ronsein, G.E.; Medeiros, M.H.G.; Cadet, J. Singlet molecular oxygen reactions with nucleic acids, lipids, and proteins. Chem. Rev., 2019, 119(3), 2043-2086.
[http://dx.doi.org/10.1021/acs.chemrev.8b00554] [PMID: 30721030]
[55]
Homma, T.; Kobayashi, S.; Fujii, J. Induction of ferroptosis by singlet oxygen generated from naphthalene endoperoxide. Biochem. Biophys. Res. Commun., 2019, 518(3), 519-525.
[http://dx.doi.org/10.1016/j.bbrc.2019.08.073] [PMID: 31445701]
[56]
Bauer, G. HOCl-dependent singlet oxygen and hydroxyl radical generation modulate and induce apoptosis of malignant cells. Anticancer Res., 2013, 33(9), 3589-3602.
[PMID: 24023284]
[57]
Bauer, G. Autoamplificatory singlet oxygen generation sensitizes tumor cells for intercellular apoptosis-inducing signaling. Mech. Ageing Dev., 2018, 172, 59-77.
[http://dx.doi.org/10.1016/j.mad.2017.11.005] [PMID: 29137940]
[58]
Klotz, L.O.; Kröncke, K.D.; Sies, H. Singlet oxygen-induced signaling effects in mammalian cells. Photochem. Photobiol. Sci., 2003, 2(2), 88-94.
[http://dx.doi.org/10.1039/b210750c] [PMID: 12664966]
[59]
Kuang, D.M.; Zhao, Q.; Peng, C.; Xu, J.; Zhang, J.P.; Wu, C.; Zheng, L. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med., 2009, 206(6), 1327-1337.
[http://dx.doi.org/10.1084/jem.20082173] [PMID: 19451266]
[60]
Kryczek, I.; Zou, L.; Rodriguez, P.; Zhu, G.; Wei, S.; Mottram, P.; Brumlik, M.; Cheng, P.; Curiel, T.; Myers, L.; Lackner, A.; Alvarez, X.; Ochoa, A.; Chen, L.; Zou, W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J. Exp. Med., 2006, 203(4), 871-881.
[http://dx.doi.org/10.1084/jem.20050930] [PMID: 16606666]
[61]
Tan, H.Y.; Wang, N.; Zhang, C.; Chan, Y.T.; Yuen, M.F.; Feng, Y. Lysyl oxidase-like 4 fosters an immunosuppressive microenvironment during hepatocarcinogenesis. Hepatology, 2021, 73(6), 2326-2341.
[http://dx.doi.org/10.1002/hep.31600] [PMID: 33068461]
[62]
Izawa, S.; Mimura, K.; Watanabe, M.; Maruyama, T.; Kawaguchi, Y.; Fujii, H.; Kono, K. Increased prevalence of tumor-infiltrating regulatory T cells is closely related to their lower sensitivity to H2O2-induced apoptosis in gastric and esophageal cancer. Cancer Immunol. Immunother., 2013, 62(1), 161-170.
[http://dx.doi.org/10.1007/s00262-012-1327-0] [PMID: 22865268]
[63]
Sakaguchi, S.; Ono, M.; Setoguchi, R.; Yagi, H.; Hori, S.; Fehervari, Z.; Shimizu, J.; Takahashi, T.; Nomura, T. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev., 2006, 212(1), 8-27.
[http://dx.doi.org/10.1111/j.0105-2896.2006.00427.x] [PMID: 16903903]
[64]
Beyer, M.; Schultze, J.L. Regulatory T cells in cancer. Blood, 2006, 108(3), 804-811.
[http://dx.doi.org/10.1182/blood-2006-02-002774] [PMID: 16861339]
[65]
Kono, K.; Salazar-Onfray, F.; Petersson, M.; Hansson, J.; Masucci, G.; Wasserman, K.; Nakazawa, T.; Anderson, P.; Kiessling, R. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur. J. Immunol., 1996, 26(6), 1308-1313.
[http://dx.doi.org/10.1002/eji.1830260620] [PMID: 8647210]
[66]
Tao, B.; Shi, J.; Shuai, S.; Zhou, H.; Zhang, H.; Li, B.; Wang, X.; Li, G.; He, H.; Zhong, J. CYB561D2 up-regulation activates STAT3 to induce immunosuppression and aggression in gliomas. J. Transl. Med., 2021, 19(1), 338.
[http://dx.doi.org/10.1186/s12967-021-02987-z] [PMID: 34372858]
[67]
Cousin, C.; Aubatin, A.; Le Gouvello, S.; Apetoh, L.; Castellano, F.; Molinier-Frenkel, V. The immunosuppressive enzyme IL4I1 promotes FoxP3 + regulatory T lymphocyte differentiation. Eur. J. Immunol., 2015, 45(6), 1772-1782.
[http://dx.doi.org/10.1002/eji.201445000] [PMID: 25778793]
[68]
Boulland, M.L.; Marquet, J.; Molinier-Frenkel, V.; Möller, P.; Guiter, C.; Lasoudris, F.; Copie-Bergman, C.; Baia, M.; Gaulard, P.; Leroy, K.; Castellano, F. Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation. Blood, 2007, 110(1), 220-227.
[http://dx.doi.org/10.1182/blood-2006-07-036210] [PMID: 17356132]
[69]
Lockhart, D.C.; Chan, A.K.; Mak, S.; Joo, H.G.; Daust, H.A.; Carritte, A.; Douville, C.C.; Goedegebuure, P.S.; Eberlein, T.J. Loss of T-cell receptor-CD3ζ and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinoma. Surgery, 2001, 129(6), 749-756.
[http://dx.doi.org/10.1067/msy.2001.114554] [PMID: 11391375]
[70]
Bronte, V.; Serafini, P.; De Santo, C.; Marigo, I.; Tosello, V.; Mazzoni, A.; Segal, D.M.; Staib, C.; Lowel, M.; Sutter, G.; Colombo, M.P.; Zanovello, P. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol., 2003, 170(1), 270-278.
[http://dx.doi.org/10.4049/jimmunol.170.1.270] [PMID: 12496409]
[71]
Mao, Y.; Poschke, I.; Wennerberg, E.; Pico de Coaña, Y.; Egyhazi Brage, S.; Schultz, I.; Hansson, J.; Masucci, G.; Lundqvist, A.; Kiessling, R. Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Res., 2013, 73(13), 3877-3887.
[http://dx.doi.org/10.1158/0008-5472.CAN-12-4115] [PMID: 23633486]
[72]
Wang, L.; Lu, Z.; Zhao, J.; Schank, M.; Cao, D.; Dang, X.; Nguyen, L.N.; Nguyen, L.N.T.; Khanal, S.; Zhang, J.; Wu, X.Y.; El Gazzar, M.; Ning, S.; Moorman, J.P.; Yao, Z.Q. Selective oxidative stress induces dual damage to telomeres and mitochondria in human T cells. Aging Cell, 2021, 20(12), e13513.
[http://dx.doi.org/10.1111/acel.13513] [PMID: 34752684]
[73]
Glorieux, C.; Xia, X.; He, Y.Q.; Hu, Y.; Cremer, K.; Robert, A.; Liu, J.; Wang, F.; Ling, J.; Chiao, P.J.; Huang, P. Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling. Redox Biol., 2021, 38, 101780.
[http://dx.doi.org/10.1016/j.redox.2020.101780] [PMID: 33171331]
[74]
Thorne, K.J.; Svvennsen, R.J.; Franks, D. Role of hydrogen peroxide in the cytotoxic reaction of T lymphocytes. Clin. Exp. Immunol., 1980, 39(2), 486-495.
[PMID: 6248285]
[75]
Freund, E.; Liedtke, K.R.; van der Linde, J.; Metelmann, H.R.; Heidecke, C.D.; Partecke, L.I.; Bekeschus, S. Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo. Sci. Rep., 2019, 9(1), 634.
[http://dx.doi.org/10.1038/s41598-018-37169-3] [PMID: 30679720]
[76]
Lu, C.; Zhou, F.; Wu, S.; Liu, L.; Xing, D. Phototherapy-induced antitumor immunity: Long-term tumor suppression effects via photoinactivation of respiratory chain oxidase-triggered superoxide anion burst. Antioxid. Redox Signal., 2016, 24(5), 249-262.
[http://dx.doi.org/10.1089/ars.2015.6334] [PMID: 26413929]
[77]
Wang, Y.; Sun, X.; Han, Y.; Wang, K.; Cheng, L.; Sun, Y.; Besenbacher, F.; Yu, M. Au@MnSe 2 core–shell nanoagent enabling immediate generation of hydroxyl radicals and simultaneous glutathione deletion free of pre-reaction for chemodynamic-photothermo-photocatalytic therapy with significant immune response. Adv. Healthc. Mater., 2022, 11(14), 2200041.
[http://dx.doi.org/10.1002/adhm.202200041] [PMID: 35481899]
[78]
Zhao, X.; Wan, X.; Huang, T.; Yao, S.; Wang, S.; Ding, Y.; Zhao, Y.; Li, Z.; Li, L. Acidity-responsive nanocages as robust reactive oxygen species generators with butterfly effects for maximizing oxidative damage and enhancing cancer therapy. J. Colloid Interface Sci., 2022, 618, 270-282.
[http://dx.doi.org/10.1016/j.jcis.2022.03.084] [PMID: 35339963]
[79]
Farber, C.M.; Liebes, L.F.; Kanganis, D.N.; Silber, R. Human B lymphocytes show greater susceptibility to H2O2 toxicity than T lymphocytes. J. Immunol., 1984, 132(5), 2543-2546.
[http://dx.doi.org/10.4049/jimmunol.132.5.2543] [PMID: 6609202]
[80]
Silber, R.; Stahl, R.L.; Farber, C.M.; Kanganis, D.; Astrow, A.; Liebes, L.F. Chronic lymphocytic leukemia lymphocytes: membrane anomalies and H2O2 vulnerability. Blood Cells, 1984, 10(2-3), 233-239.
[PMID: 6336165]
[81]
Izawa, S.; Kono, K.; Mimura, K.; Kawaguchi, Y.; Watanabe, M.; Maruyama, T.; Fujii, H. H2O2 production within tumor microenvironment inversely correlated with infiltration of CD56dim NK cells in gastric and esophageal cancer: possible mechanisms of NK cell dysfunction. Cancer Immunol. Immunother., 2011, 60(12), 1801-1810.
[http://dx.doi.org/10.1007/s00262-011-1082-7] [PMID: 21811786]
[82]
Klopotowska, M.; Bajor, M.; Graczyk-Jarzynka, A.; Kraft, A.; Pilch, Z.; Zhylko, A.; Firczuk, M.; Baranowska, I.; Lazniewski, M.; Plewczynski, D.; Goral, A.; Soroczynska, K.; Domagala, J.; Marhelava, K.; Slusarczyk, A.; Retecki, K.; Ramji, K.; Krawczyk, M.; Temples, M.N.; Sharma, B.; Lachota, M.; Netskar, H.; Malmberg, K.J.; Zagozdzon, R.; Winiarska, M. PRDX-1 supports the survival and antitumor activity of primary and CAR-modified nk cells under oxidative stress. Cancer Immunol. Res., 2022, 10(2), 228-244.
[http://dx.doi.org/10.1158/2326-6066.CIR-20-1023] [PMID: 34853030]
[83]
Zhou, X.; Zhao, R.; Schwarz, K.; Mangeat, M.; Schwarz, E.C.; Hamed, M.; Bogeski, I.; Helms, V.; Rieger, H.; Qu, B. Bystander cells enhance NK cytotoxic efficiency by reducing search time. Sci. Rep., 2017, 7(1), 44357.
[http://dx.doi.org/10.1038/srep44357] [PMID: 28287155]
[84]
Upadhyay, S.; Vaish, S.; Dhiman, M. Hydrogen peroxide-induced oxidative stress and its impact on innate immune responses in lung carcinoma A549 cells. Mol. Cell. Biochem., 2019, 450(1-2), 135-147.
[http://dx.doi.org/10.1007/s11010-018-3380-2] [PMID: 29938378]
[85]
Li, F.; Kitajima, S.; Kohno, S.; Yoshida, A.; Tange, S.; Sasaki, S.; Okada, N.; Nishimoto, Y.; Muranaka, H.; Nagatani, N.; Suzuki, M.; Masuda, S.; Thai, T.C.; Nishiuchi, T.; Tanaka, T.; Barbie, D.A.; Mukaida, N.; Takahashi, C. Retinoblastoma inactivation induces a protumoral microenvironment via enhanced CCL2 secretion. Cancer Res., 2019, 79(15), 3903-3915.
[http://dx.doi.org/10.1158/0008-5472.CAN-18-3604] [PMID: 31189648]
[86]
Sang, Y.; Deng, Q.; Cao, F.; Liu, Z.; You, Y.; Liu, H.; Ren, J.; Qu, X. Remodeling macrophages by an iron nanotrap for tumor growth suppression. ACS Nano, 2021, 15(12), 19298-19309.
[http://dx.doi.org/10.1021/acsnano.1c05392] [PMID: 34783526]
[87]
Martinez-Marin, D.; Jarvis, C.; Nelius, T.; de Riese, W.; Volpert, O.V.; Filleur, S. PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro. PLoS One, 2017, 12(4), e0174968.
[http://dx.doi.org/10.1371/journal.pone.0174968] [PMID: 28403150]
[88]
Zuo, W.; Chen, W.; Liu, J.; Huang, S.; Chen, L.; Liu, Q.; Liu, N.; Jin, Q.; Li, Y.; Wang, P.; Zhu, X. Macrophage-mimic hollow mesoporous fe-based nanocatalysts for self-amplified chemodynamic therapy and metastasis inhibition via tumor microenvironment remodeling. ACS Appl. Mater. Interfaces, 2022, 14(4), 5053-5065.
[http://dx.doi.org/10.1021/acsami.1c22432] [PMID: 35040616]
[89]
Ishihara, Y.; Fujii, T.; Iijima, H.; Saito, K.; Matsunaga, K. The role of neutrophils as cytotoxic cells in lung metastasis: suppression of tumor cell metastasis by a biological response modifier (PSK). In vivo, 1998, 12(2), 175-182.
[PMID: 9627799]
[90]
Rosen, G.M.; Pou, S.; Ramos, C.L.; Cohen, M.S.; Britigan, B.E. Free radicals and phagocytic cells. FASEB J., 1995, 9(2), 200-209.
[http://dx.doi.org/10.1096/fasebj.9.2.7540156] [PMID: 7540156]
[91]
Murphy, M.S.C.; Britigan, B.E.; Hassett, D.J.; Rosen, G.M. Phagocytes, O2 reduction, and hydroxyl radical. Clin. Infect. Dis., 1988, 10(6), 1088-1096.
[http://dx.doi.org/10.1093/clinids/10.6.1088] [PMID: 2849797]
[92]
Butcher, L.D.; den Hartog, G.; Ernst, P.B.; Crowe, S.E. Oxidative stress resulting from Helicobacter pylori infection contributes to gastric carcinogenesis. Cell. Mol. Gastroenterol. Hepatol., 2017, 3(3), 316-322.
[http://dx.doi.org/10.1016/j.jcmgh.2017.02.002] [PMID: 28462373]
[93]
Hoeben, A.; Landuyt, B.; Highley, M.S.; Wildiers, H.; Van Oosterom, A.T.; De Bruijn, E.A. Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev., 2004, 56(4), 549-580.
[http://dx.doi.org/10.1124/pr.56.4.3] [PMID: 15602010]
[94]
Arneth, B. Tumor microenvironment. Medicina (Kaunas), 2019, 56(1), 15.
[http://dx.doi.org/10.3390/medicina56010015] [PMID: 31906017]
[95]
Zeng, Y.; Opeskin, K.; Horvath, L.G.; Sutherland, R.L.; Williams, E.D. Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate, 2005, 65(3), 222-230.
[http://dx.doi.org/10.1002/pros.20288] [PMID: 15948136]
[96]
Jennbacken, K.; Vallbo, C.; Wang, W.; Damber, J.E. Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis. Prostate, 2005, 65(2), 110-116.
[http://dx.doi.org/10.1002/pros.20276] [PMID: 15880525]
[97]
Muders, M.H.; Zhang, H.; Wang, E.; Tindall, D.J.; Datta, K. Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1. Cancer Res., 2009, 69(15), 6042-6048.
[http://dx.doi.org/10.1158/0008-5472.CAN-09-0552] [PMID: 19638584]
[98]
Abumaree, M.H.; Hakami, M.; Abomaray, F.M.; Alshabibi, M.A.; Kalionis, B.; Al Jumah, M.A.; AlAskar, A.S. Human chorionic villous mesenchymal stem/stromal cells modify the effects of oxidative stress on endothelial cell functions. Placenta, 2017, 59, 74-86.
[http://dx.doi.org/10.1016/j.placenta.2017.05.001] [PMID: 28502524]
[99]
Basmaeil, Y.; Al Subayyil, A.; Abumaree, M.; Khatlani, T. Conditions mimicking the cancer microenvironment modulate the functional outcome of human chorionic villus mesenchymal stem/stromal cells in vitro. Front. Cell Dev. Biol., 2021, 9, 650125.
[http://dx.doi.org/10.3389/fcell.2021.650125] [PMID: 34235143]
[100]
Zhu, J.W.; Yu, B.M.; Ji, Y.B.; Zheng, M.H.; Li, D.H. Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer. World J. Gastroenterol., 2002, 8(1), 153-157.
[http://dx.doi.org/10.3748/wjg.v8.i1.153] [PMID: 11833093]
[101]
Culp, W.D.; Neal, R.; Massey, R.; Egevad, L.; Pisa, P.; Garland, D. Proteomic analysis of tumor establishment and growth in the B16-F10 mouse melanoma model. J. Proteome Res., 2006, 5(6), 1332-1343.
[http://dx.doi.org/10.1021/pr060059q] [PMID: 16739985]
[102]
Du, X.; Xu, Q.; Pan, D.; Xu, D.; Niu, B.; Hong, W.; Zhang, R.; Li, X.; Chen, S. HIC-5 in cancer-associated fibroblasts contributes to esophageal squamous cell carcinoma progression. Cell Death Dis., 2019, 10(12), 873.
[http://dx.doi.org/10.1038/s41419-019-2114-z] [PMID: 31740661]
[103]
Martinez-Outschoorn, U.E.; Balliet, R.M.; Lin, Z.; Whitaker-Menezes, D.; Howell, A.; Sotgia, F.; Lisanti, M.P. Hereditary ovarian cancer and two-compartment tumor metabolism. Cell Cycle, 2012, 11(22), 4152-4166.
[http://dx.doi.org/10.4161/cc.22226] [PMID: 23047606]
[104]
Toullec, A.; Gerald, D.; Despouy, G.; Bourachot, B.; Cardon, M.; Lefort, S.; Richardson, M.; Rigaill, G.; Parrini, M.C.; Lucchesi, C.; Bellanger, D.; Stern, M.H.; Dubois, T.; Sastre-Garau, X.; Delattre, O.; Vincent-Salomon, A.; Mechta-Grigoriou, F. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol. Med., 2010, 2(6), 211-230.
[http://dx.doi.org/10.1002/emmm.201000073] [PMID: 20535745]
[105]
Balliet, R.M.; Capparelli, C.; Guido, C.; Pestell, T.G.; Martinez-Outschoorn, U.E.; Lin, Z.; Whitaker-Menezes, D.; Chiavarina, B.; Pestell, R.G.; Howell, A.; Sotgia, F.; Lisanti, M.P. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth. Cell Cycle, 2011, 10(23), 4065-4073.
[http://dx.doi.org/10.4161/cc.10.23.18254] [PMID: 22129993]
[106]
Liang, L.; Li, W.; Li, X.; Jin, X.; Liao, Q.; Li, Y.; Zhou, Y. ‘Reverse Warburg effect’ of cancer-associated fibroblasts (Review). Int. J. Oncol., 2022, 60(6), 67.
[http://dx.doi.org/10.3892/ijo.2022.5357] [PMID: 35425996]
[107]
Jezierska-Drutel, A.; Rosenzweig, S.A.; Neumann, C.A. Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv. Cancer Res., 2013, 119, 107-125.
[http://dx.doi.org/10.1016/B978-0-12-407190-2.00003-4] [PMID: 23870510]
[108]
Martinez-Outschoorn, U.E.; Lin, Z.; Trimmer, C.; Flomenberg, N.; Wang, C.; Pavlides, S.; Pestell, R.G.; Howell, A.; Sotgia, F.; Lisanti, M.P. Cancer cells metabolically “fertilize” the tumor microenvironment with hydrogen peroxide, driving the Warburg effect. Cell Cycle, 2011, 10(15), 2504-2520.
[http://dx.doi.org/10.4161/cc.10.15.16585] [PMID: 21778829]
[109]
Lisanti, M.P.; Martinez-Outschoorn, U.E.; Lin, Z.; Pavlides, S.; Whitaker-Menezes, D.; Pestell, R.G.; Howell, A.; Sotgia, F. Hydrogen peroxide fuels aging, inflammation, cancer metabolism and metastasis. Cell Cycle, 2011, 10(15), 2440-2449.
[http://dx.doi.org/10.4161/cc.10.15.16870] [PMID: 21734470]
[110]
Hsieh, C.L.; Liu, C.M.; Chen, H.A.; Yang, S.T.; Shigemura, K.; Kitagawa, K.; Yamamichi, F.; Fujisawa, M.; Liu, Y.R.; Lee, W.H.; Chen, K.C.; Shen, C.N.; Lin, C.C.; Chung, L.W.K.; Sung, S.Y. Reactive oxygen species–mediated switching expression of MMP-3 in stromal fibroblasts and cancer cells during prostate cancer progression. Sci. Rep., 2017, 7(1), 9065.
[http://dx.doi.org/10.1038/s41598-017-08835-9] [PMID: 28831065]
[111]
Martinez-Outschoorn, U.E.; Trimmer, C.; Lin, Z.; Whitaker-Menezes, D.; Chiavarina, B.; Zhou, J.; Wang, C.; Pavlides, S.; Martinez-Cantarin, M.P.; Capozza, F.; Witkiewicz, A.K.; Flomenberg, N.; Howell, A.; Pestell, R.G.; Caro, J.; Lisanti, M.P.; Sotgia, F. Autophagy in cancer associated fibroblasts promotes tumor cell survival. Cell Cycle, 2010, 9(17), 3515-3533.
[http://dx.doi.org/10.4161/cc.9.17.12928] [PMID: 20855962]
[112]
Trimmer, C.; Sotgia, F.; Whitaker-Menezes, D.; Balliet, R.M.; Eaton, G.; Martinez-Outschoorn, U.E.; Pavlides, S.; Howell, A.; Iozzo, R.V.; Pestell, R.G.; Scherer, P.E.; Capozza, F.; Lisanti, M.P. Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment. Cancer Biol. Ther., 2011, 11(4), 383-394.
[http://dx.doi.org/10.4161/cbt.11.4.14101] [PMID: 21150282]
[113]
Golden, B.O.; Griess, B.; Mir, S.; Fitzgerald, M.; Kuperwasser, C.; Domann, F.; Teoh-Fitzgerald, M. Extracellular superoxide dismutase inhibits hepatocyte growth factor-mediated breast cancer-fibroblast interactions. Oncotarget, 2017, 8(64), 107390-107408.
[http://dx.doi.org/10.18632/oncotarget.22379] [PMID: 29296173]
[114]
Abdian, N.; Ghasemi-Dehkordi, P.; Hashemzadeh-Chaleshtori, M.; Ganji-Arjenaki, M.; Doosti, A.; Amiri, B. Comparison of human dermal fibroblasts (HDFs) growth rate in culture media supplemented with or without basic fibroblast growth factor (bFGF). Cell Tissue Bank., 2015, 16(4), 487-495.
[http://dx.doi.org/10.1007/s10561-015-9494-9] [PMID: 25605061]
[115]
Ma, C.; Bower, K.A.; Chen, G.; Shi, X.; Ke, Z.J.; Luo, J. Interaction between ERK and GSK3beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells. J. Biol. Chem., 2008, 283(14), 9248-9256.
[http://dx.doi.org/10.1074/jbc.M707316200] [PMID: 18263590]
[116]
Wang, Z.; Zheng, R.; Fu, S.; Chen, Y.; Duan, G.; Qin, D.; Liu, G. Role of superoxide anion on the proliferation and c-Ha- ras or p53 expression in prostate cancer cell line PC3. Urol. Res., 1998, 26(5), 349-353.
[http://dx.doi.org/10.1007/s002400050068] [PMID: 9840345]
[117]
Arnold, R.S.; Shi, J.; Murad, E.; Whalen, A.M.; Sun, C.Q.; Polavarapu, R.; Parthasarathy, S.; Petros, J.A.; Lambeth, J.D. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1. Proc. Natl. Acad. Sci. USA, 2001, 98(10), 5550-5555.
[http://dx.doi.org/10.1073/pnas.101505898] [PMID: 11331784]
[118]
Arbiser, J.L.; Petros, J.; Klafter, R.; Govindajaran, B.; McLaughlin, E.R.; Brown, L.F.; Cohen, C.; Moses, M.; Kilroy, S.; Arnold, R.S.; Lambeth, J.D. Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. USA, 2002, 99(2), 715-720.
[http://dx.doi.org/10.1073/pnas.022630199] [PMID: 11805326]
[119]
Kuroki, M.; Voest, E.E.; Amano, S.; Beerepoot, L.V.; Takashima, S.; Tolentino, M.; Kim, R.Y.; Rohan, R.M.; Colby, K.A.; Yeo, K.T.; Adamis, A.P. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest., 1996, 98(7), 1667-1675.
[http://dx.doi.org/10.1172/JCI118962] [PMID: 8833917]
[120]
Maehata, Y.; Ozawa, S.; Kobayashi, K.; Kato, Y.; Yoshino, F.; Miyamoto, C.; Izukuri, K.; Kubota, E.; Hata, R.I.; Lee, M.C.I. Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells. Free Radic. Res., 2010, 44(8), 913-924.
[http://dx.doi.org/10.3109/10715762.2010.490836] [PMID: 20815772]
[121]
Kang, D.H.; Lee, D.J.; Lee, K.W.; Park, Y.S.; Lee, J.Y.; Lee, S.H.; Koh, Y.J.; Koh, G.Y.; Choi, C.; Yu, D.Y.; Kim, J.; Kang, S.W. Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol. Cell, 2011, 44(4), 545-558.
[http://dx.doi.org/10.1016/j.molcel.2011.08.040] [PMID: 22099303]
[122]
Pez, F.; Dayan, F.; Durivault, J.; Kaniewski, B.; Aimond, G.; Le Provost, G.S.; Deux, B.; Clézardin, P.; Sommer, P.; Pouysségur, J.; Reynaud, C. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res., 2011, 71(5), 1647-1657.
[http://dx.doi.org/10.1158/0008-5472.CAN-10-1516] [PMID: 21239473]
[123]
Payne, S.L.; Fogelgren, B.; Hess, A.R.; Seftor, E.A.; Wiley, E.L.; Fong, S.F.T.; Csiszar, K.; Hendrix, M.J.C.; Kirschmann, D.A. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res., 2005, 65(24), 11429-11436.
[http://dx.doi.org/10.1158/0008-5472.CAN-05-1274] [PMID: 16357151]
[124]
Milla Sanabria, L.; Rodríguez, M.E.; Cogno, I.S.; Rumie Vittar, N.B.; Pansa, M.F.; Lamberti, M.J.; Rivarola, V.A. Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment. Biochim. Biophys. Acta, 2013, 1835(1), 36-45.
[PMID: 23046998]
[125]
Burlaka, A.P.; Ganusevich, I.I.; Lozovska, Y.V.; Lukianova, N.Y.; Chekhun, V.F. Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma. Exp. Oncol., 2015, 37(1), 36-39.
[http://dx.doi.org/10.31768/2312-8852.2015.37(1):36-39] [PMID: 25804229]
[126]
Ma, Z.; Liu, X.; Zhang, Q.; Yu, Z.; Gao, D. Carvedilol suppresses malignant proliferation of mammary epithelial cells through inhibition of the ROS-mediated PI3K/AKT signaling pathway. Oncol. Rep., 2019, 41(2), 811-818.
[PMID: 30483797]
[127]
Wang, Y.J.; Yang, M.C.; Pan, M.H. Dihydrolipoic acid inhibits tetrachlorohydroquinone-induced tumor promotion through prevention of oxidative damage. Food Chem. Toxicol., 2008, 46(12), 3739-3748.
[http://dx.doi.org/10.1016/j.fct.2008.09.064] [PMID: 18951944]
[128]
Omenn, G.S.; Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Glass, A.; Keogh, J.P.; Meyskens, F.L., Jr; Valanis, B.; Williams, J.H., Jr; Barnhart, S.; Hammar, S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med., 1996, 334(18), 1150-1155.
[http://dx.doi.org/10.1056/NEJM199605023341802] [PMID: 8602180]
[129]
Klein, E.A.; Thompson, I.M., Jr; Tangen, C.M.; Crowley, J.J.; Lucia, M.S.; Goodman, P.J.; Minasian, L.M.; Ford, L.G.; Parnes, H.L.; Gaziano, J.M.; Karp, D.D.; Lieber, M.M.; Walther, P.J.; Klotz, L.; Parsons, J.K.; Chin, J.L.; Darke, A.K.; Lippman, S.M.; Goodman, G.E.; Meyskens, F.L., Jr; Baker, L.H. Vitamin E and the risk of prostate cancer. JAMA, 2011, 306(14), 1549-1556.
[http://dx.doi.org/10.1001/jama.2011.1437] [PMID: 21990298]
[130]
Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med., 1994, 330(15), 1029-1035.
[http://dx.doi.org/10.1056/NEJM199404143301501] [PMID: 8127329]
[131]
Singh, A.; Boldin-Adamsky, S.; Thimmulappa, R.K.; Rath, S.K.; Ashush, H.; Coulter, J.; Blackford, A.; Goodman, S.N.; Bunz, F.; Watson, W.H.; Gabrielson, E.; Feinstein, E.; Biswal, S. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res., 2008, 68(19), 7975-7984.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-1401] [PMID: 18829555]
[132]
DeNicola, G.M.; Karreth, F.A.; Humpton, T.J.; Gopinathan, A.; Wei, C.; Frese, K.; Mangal, D.; Yu, K.H.; Yeo, C.J.; Calhoun, E.S.; Scrimieri, F.; Winter, J.M.; Hruban, R.H.; Iacobuzio-Donahue, C.; Kern, S.E.; Blair, I.A.; Tuveson, D.A. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature, 2011, 475(7354), 106-109.
[http://dx.doi.org/10.1038/nature10189] [PMID: 21734707]
[133]
Bauer, A.K.; Cho, H.Y.; Miller-DeGraff, L.; Walker, C.; Helms, K.; Fostel, J.; Yamamoto, M.; Kleeberger, S.R. Targeted deletion of Nrf2 reduces urethane-induced lung tumor development in mice. PLoS One, 2011, 6(10), e26590.
[http://dx.doi.org/10.1371/journal.pone.0026590] [PMID: 22039513]
[134]
Watson, J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol., 2013, 3(1), 120144.
[http://dx.doi.org/10.1098/rsob.120144] [PMID: 23303309]
[135]
Guo, L.; Tan, K.; Wang, H.; Zhang, X. Pterostilbene inhibits hepatocellular carcinoma through p53/SOD2/ROS-mediated mitochondrial apoptosis. Oncol. Rep., 2016, 36(6), 3233-3240.
[http://dx.doi.org/10.3892/or.2016.5151] [PMID: 27748853]
[136]
Zou, J.; Zhang, Y.; Sun, J.; Wang, X.; Tu, H.; Geng, S.; Liu, R.; Chen, Y.; Bi, Z. Deoxyelephantopin induces reactive oxygen species-mediated apoptosis and autophagy in human osteosarcoma cells. Cell. Physiol. Biochem., 2017, 42(5), 1812-1821.
[http://dx.doi.org/10.1159/000479537] [PMID: 28750364]
[137]
Renaudin, X. Reactive oxygen species and DNA damage response in cancer. Int. Rev. Cell Mol. Biol., 2021, 364, 139-161.
[http://dx.doi.org/10.1016/bs.ircmb.2021.04.001] [PMID: 34507782]
[138]
Jackson, A.L.; Loeb, L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat. Res., 2001, 477(1-2), 7-21.
[http://dx.doi.org/10.1016/S0027-5107(01)00091-4] [PMID: 11376682]
[139]
Xia, X.; Yang, X.; Huang, P.; Yan, D. ROS-responsive nanoparticles formed from RGD–epothilone b conjugate for targeted cancer therapy. ACS Appl. Mater. Interfaces, 2020, 12(16), 18301-18308.
[http://dx.doi.org/10.1021/acsami.0c00650] [PMID: 32242653]
[140]
Zhang, Z.; Lu, Z.; Yuan, Q.; Zhang, C.; Tang, Y. ROS-Responsive and active targeted drug delivery based on conjugated polymer nanoparticles for synergistic chemo-/photodynamic therapy. J. Mater. Chem. B Mater. Biol. Med., 2021, 9(9), 2240-2248.
[http://dx.doi.org/10.1039/D0TB02996C] [PMID: 33596297]
[141]
Yun, K.; Guo, J.; Zhu, R.; Wang, T.; Zhang, X.; Pan, H.; Pan, W. Design of ROS-responsive hyaluronic acid–methotrexate conjugates for synergistic chemo-photothermal therapy for cancer. Mol. Pharm., 2022, 19(9), 3323-3335.
[http://dx.doi.org/10.1021/acs.molpharmaceut.2c00472] [PMID: 35900105]
[142]
Mokwena, M.G.; Kruger, C.A.; Ivan, M.T.; Heidi, A. A review of nanoparticle photosensitizer drug delivery uptake systems for photodynamic treatment of lung cancer. Photodiagn. Photodyn. Ther., 2018, 22, 147-154.
[http://dx.doi.org/10.1016/j.pdpdt.2018.03.006] [PMID: 29588217]
[143]
Li, S.Y.; Cheng, H.; Qiu, W.X.; Zhang, L.; Wan, S.S.; Zeng, J.Y.; Zhang, X.Z. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Biomaterials, 2017, 142, 149-161.
[http://dx.doi.org/10.1016/j.biomaterials.2017.07.026] [PMID: 28735175]
[144]
Baldea, I.; Giurgiu, L.; Teacoe, I.D.; Olteanu, D.E.; Olteanu, F.C.; Clichici, S.; Filip, G.A. Photodynamic therapy in melanoma - where do we stand? Curr. Med. Chem., 2019, 25(40), 5540-5563.
[http://dx.doi.org/10.2174/0929867325666171226115626] [PMID: 29278205]
[145]
Ming, H.; Li, B.; Tian, H.; Zhou, L.; Jiang, J.; Zhang, T.; Qiao, L.; Wu, P.; Nice, E.C.; Zhang, W.; He, W.; Huang, C.; Zhang, H. A minimalist and robust chemo-photothermal nanoplatform capable of augmenting autophagy-modulated immune response against breast cancer. Mater. Today Bio, 2022, 15, 100289.
[http://dx.doi.org/10.1016/j.mtbio.2022.100289] [PMID: 35634171]
[146]
Wang, C.; Wang, J.; Zhang, X.; Yu, S.; Wen, D.; Hu, Q.; Ye, Y.; Bomba, H.; Hu, X.; Liu, Z.; Dotti, G.; Gu, Z. In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy. Sci. Transl. Med., 2018, 10(429), eaan3682.
[http://dx.doi.org/10.1126/scitranslmed.aan3682] [PMID: 29467299]
[147]
Paduch, R.; Kandefer-Szerszeń, M.; Piersiak, T. The importance of release of proinflammatory cytokines, ROS, and NO in different stages of colon carcinoma growth and metastasis after treatment with cytotoxic drugs. Oncol. Res., 2009, 18(9), 419-436.
[http://dx.doi.org/10.3727/096504010X12671222663593] [PMID: 20524400]
[148]
Jezierska-Drutel, A.; Attaran, S.; Hopkins, B.L.; Skoko, J.J.; Rosenzweig, S.A.; Neumann, C.A. The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases. BMC Cancer, 2019, 19(1), 812.
[http://dx.doi.org/10.1186/s12885-019-6031-4] [PMID: 31419957]
[149]
Letchoumy, P.V.; Chandra Mohan, K.V.P.; Stegeman, J.J.; Gelboin, H.V.; Hara, Y.; Nagini, S. in vitro antioxidative potential of lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen activation, DNA damage, proliferation, invasion, and angiogenesis during experimental oral carcinogenesis. Oncol. Res., 2008, 17(5), 193-203.
[http://dx.doi.org/10.3727/096504008786111365] [PMID: 18980016]
[150]
Horinaka, A.; Sakurai, D.; Ihara, F.; Makita, Y.; Kunii, N.; Motohashi, S.; Nakayama, T.; Okamoto, Y. Invariant NKT cells are resistant to circulating CD15+ myeloid-derived suppressor cells in patients with head and neck cancer. Cancer Sci., 2016, 107(3), 207-216.
[http://dx.doi.org/10.1111/cas.12866] [PMID: 26679292]
[151]
Lasoudris, F.; Cousin, C.; Prevost-Blondel, A.; Martin-Garcia, N.; Abd-Alsamad, I.; Ortonne, N.; Farcet, J.P.; Castellano, F.; Molinier-Frenkel, V. IL4I1: an inhibitor of the CD8+ antitumor T-cell response in vivo. Eur. J. Immunol., 2011, 41(6), 1629-1638.
[http://dx.doi.org/10.1002/eji.201041119] [PMID: 21469114]
[152]
Otsuji, M.; Kimura, Y.; Aoe, T.; Okamoto, Y.; Saito, T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 ζ chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. USA, 1996, 93(23), 13119-13124.
[http://dx.doi.org/10.1073/pnas.93.23.13119] [PMID: 8917554]
[153]
Kwon, D.; Choi, I.H. Hydrogen peroxide upregulates TNF-related apoptosis-inducing ligand (TRAIL) expression in human astroglial cells, and augments apoptosis of T cells. Yonsei Med. J., 2006, 47(4), 551-557.
[http://dx.doi.org/10.3349/ymj.2006.47.4.551] [PMID: 16941746]
[154]
Kitamura, T.; Doughty-Shenton, D.; Cassetta, L.; Fragkogianni, S.; Brownlie, D.; Kato, Y.; Carragher, N.; Pollard, J.W. Monocytes differentiate to immune suppressive precursors of metastasis-associated macrophages in mouse models of metastatic breast cancer. Front. Immunol., 2018, 8, 2004.
[http://dx.doi.org/10.3389/fimmu.2017.02004] [PMID: 29387063]
[155]
Qiu, J.; Zhang, T.; Zhu, X.; Yang, C.; Wang, Y.; Zhou, N.; Ju, B.; Zhou, T.; Deng, G.; Qiu, C. Hyperoside induces breast cancer cells apoptosis via ROS-mediated NF-κB signaling pathway. Int. J. Mol. Sci., 2019, 21(1), 131.
[http://dx.doi.org/10.3390/ijms21010131] [PMID: 31878204]
[156]
Si, L.; Fu, J.; Liu, W.; Hayashi, T.; Nie, Y.; Mizuno, K.; Hattori, S.; Fujisaki, H.; Onodera, S.; Ikejima, T. Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion. Mol. Cell. Biochem., 2020, 463(1-2), 189-201.
[http://dx.doi.org/10.1007/s11010-019-03640-6] [PMID: 31612353]
[157]
Lin, H.; Liu, X.; Yu, J.; Hua, F.; Hu, Z. Antioxidant N-acetylcysteine attenuates hepatocarcinogenesis by inhibiting ROS/ER stress in TLR2 deficient mouse. PLoS One, 2013, 8(10), e74130.
[http://dx.doi.org/10.1371/journal.pone.0074130] [PMID: 24098333]
[158]
Nishikawa, M.; Hashida, M.; Takakura, Y. Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis. Adv. Drug Deliv. Rev., 2009, 61(4), 319-326.
[http://dx.doi.org/10.1016/j.addr.2009.01.001] [PMID: 19385054]
[159]
Zhang, Q.; Huang, Y.; Yang, R.; Mu, J.; Zhou, Z.; Sun, M. Poly-antioxidants for enhanced anti-miR-155 delivery and synergistic therapy of metastatic breast cancer. Biomater. Sci., 2022, 10(13), 3637-3646.
[http://dx.doi.org/10.1039/D1BM02022F] [PMID: 35648436]
[160]
Travassos, I.O.; Mello-Andrade, F.; Caldeira, R.P.; Pires, W.C.; da Silva, P.F.F.; Correa, R.S.; Teixeira, T.; Martins-Oliveira, A.; Batista, A.A.; de Silveira-Lacerda, E.P. Ruthenium (II)/allopurinol complex inhibits breast cancer progression via multiple targets. J. Biol. Inorg. Chem., 2021, 26(4), 385-401.
[http://dx.doi.org/10.1007/s00775-021-01862-y] [PMID: 33837856]
[161]
Factor, V.M.; Laskowska, D.; Jensen, M.R.; Woitach, J.T.; Popescu, N.C.; Thorgeirsson, S.S. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc. Natl. Acad. Sci. USA, 2000, 97(5), 2196-2201.
[http://dx.doi.org/10.1073/pnas.040428797] [PMID: 10681450]
[162]
Tapiero, H.; Townsend, D.M.; Tew, K.D. The role of carotenoids in the prevention of human pathologies. Biomed. Pharmacother., 2004, 58(2), 100-110.
[http://dx.doi.org/10.1016/j.biopha.2003.12.006] [PMID: 14992791]
[163]
Nishikawa, M.; Hyoudou, K.; Kobayashi, Y.; Umeyama, Y.; Takakura, Y.; Hashida, M. Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes. J. Control. Release, 2005, 109(1-3), 101-107.
[http://dx.doi.org/10.1016/j.jconrel.2005.09.017] [PMID: 16256238]
[164]
Xu, G.; Yu, B.; Wang, R.; Jiang, J.; Wen, F.; Shi, X. Astragalin flavonoid inhibits proliferation in human lung carcinoma cells mediated via induction of caspase-dependent intrinsic pathway, ROS production, cell migration and invasion inhibition and targeting JAK/STAT signalling pathway. Cell. Mol. Biol., 2021, 67(2), 44-49.
[http://dx.doi.org/10.14715/cmb/2021.67.2.7] [PMID: 34817340]
[165]
Phan, T.N.; Kim, O.; Ha, M.T.; Hwangbo, C.; Min, B.S.; Lee, J.H. Albanol B from mulberries exerts anti-cancer effect through mitochondria ROS production in lung cancer cells and suppresses in vivo tumor growth. Int. J. Mol. Sci., 2020, 21(24), 9502.
[http://dx.doi.org/10.3390/ijms21249502] [PMID: 33327489]
[166]
Jia, X.B.; Zhang, Q.; Xu, L.; Yao, W.J.; Wei, L. Lotus leaf flavonoids induce apoptosis of human lung cancer A549 cells through the ROS/p38 MAPK pathway. Biol. Res., 2021, 54(1), 7.
[http://dx.doi.org/10.1186/s40659-021-00330-w] [PMID: 33653412]
[167]
Qu, X.; Sheng, J.; Shen, L.; Su, J.; Xu, Y.; Xie, Q.; Wu, Y.; Zhang, X.; Sun, L. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS. PLoS One, 2017, 12(3), e0173712.
[http://dx.doi.org/10.1371/journal.pone.0173712] [PMID: 28301876]
[168]
Schluterman, M.K.; Chapman, S.L.; Korpanty, G.; Ozumi, K.; Fukai, T.; Yanagisawa, H.; Brekken, R.A. Loss of fibulin-5 binding to β1 integrins inhibits tumor growth by increasing the level of ROS. Dis. Model. Mech., 2010, 3(5-6), 333-342.
[http://dx.doi.org/10.1242/dmm.003707] [PMID: 20197418]
[169]
Li, D.; Kou, Y.; Gao, Y.; Liu, S.; Yang, P.; Hasegawa, T.; Su, R.; Guo, J.; Li, M. Oxaliplatin induces the PARP1-mediated parthanatos in oral squamous cell carcinoma by increasing production of ROS. Aging (Albany NY), 2021, 13(3), 4242-4257.
[http://dx.doi.org/10.18632/aging.202386] [PMID: 33495407]
[170]
Zhou, L.; Yang, C.; Zhong, W.; Wang, Q.; Zhang, D.; Zhang, J.; Xie, S.; Xu, M. Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells. Biochem. Pharmacol., 2021, 193, 114813.
[http://dx.doi.org/10.1016/j.bcp.2021.114813] [PMID: 34673014]
[171]
Chen, Y.C.; Shen, S.C.; Chow, J.M.; Ko, C.; Tseng, S.W. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int. J. Oncol., 2004, 25(3), 661-670.
[http://dx.doi.org/10.3892/ijo.25.3.661] [PMID: 15289867]
[172]
Li, Y.; Zhou, Y.; Wang, M.; Lin, X.; Zhang, Y.; Laurent, I.; Zhong, Y.; Li, J. Ampelopsin inhibits breast cancer cell growth through mitochondrial apoptosis pathway. Biol. Pharm. Bull., 2021, 44(11), 1738-1745.
[http://dx.doi.org/10.1248/bpb.b21-00470] [PMID: 34470980]
[173]
Alam, M.; Hasan, G.M.; Ansari, M.M.; Sharma, R.; Yadav, D.K.; Hassan, M.I. Therapeutic implications and clinical manifestations of thymoquinone. Phytochemistry, 2022, 200, 113213.
[http://dx.doi.org/10.1016/j.phytochem.2022.113213] [PMID: 35472482]
[174]
Ko, C.H.; Shen, S.C.; Yang, L.Y.; Lin, C.W.; Chen, Y.C. Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells. Int. J. Cancer, 2007, 121(8), 1670-1679.
[http://dx.doi.org/10.1002/ijc.22910] [PMID: 17597109]
[175]
Wang, M.; Li, K.; Zou, Z.; Li, L.; Zhu, L.; Wang, Q.; Gao, W.; Wang, Y.; Huang, W.; Liu, R.; Yao, K.; Liu, Q. Piperidine nitroxide Tempol enhances cisplatin-induced apoptosis in ovarian cancer cells. Oncol. Lett., 2018, 16(4), 4847-4854.
[http://dx.doi.org/10.3892/ol.2018.9289] [PMID: 30250550]
[176]
Zou, Z.W.; Liu, T.; Li, Y.; Chen, P.; Peng, X.; Ma, C.; Zhang, W.J.; Li, P.D. Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS. Redox Biol., 2018, 16, 226-236.
[http://dx.doi.org/10.1016/j.redox.2018.02.025] [PMID: 29525603]
[177]
Jeon, H.; Jin, Y.; Myung, C.S.; Heo, K.S. Ginsenoside-Rg2 exerts anti-cancer effects through ROS-mediated AMPK activation associated mitochondrial damage and oxidation in MCF-7 cells. Arch. Pharm. Res., 2021, 44(7), 702-712.
[http://dx.doi.org/10.1007/s12272-021-01345-3] [PMID: 34302638]
[178]
Biswas, S.; Zhao, X.; Mone, A.P.; Mo, X.; Vargo, M.; Jarjoura, D.; Byrd, J.C.; Muthusamy, N. Arsenic trioxide and ascorbic acid demonstrate promising activity against primary human CLL cells in vitro. Leuk. Res., 2010, 34(7), 925-931.
[http://dx.doi.org/10.1016/j.leukres.2010.01.020] [PMID: 20171736]

Rights & Permissions Print Cite
Article Metrics
47
1
Wayfinder Image
Open Access Journals Promotions
World Antimicrobial Awareness Week
© 2024 Bentham Science Publishers | Privacy Policy